A Summary of Reviews in Fiscal Years 2022 and 2023 of Manufacturers’ Noncompliance with Veterans Health Care Act Provisions on Pharmaceutical Pricing
In line with the Veterans Health Care Act of 1992 (referred to in this report as the public law), the OIG conducts reviews to determine whether certain manufacturers (1) made all their covered drugs available at a discount to the government through a Federal Supply Schedule (FSS) contract and (2)...